UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Warfarin dosing algorithms: A systematic review

British journal of clinical pharmacology, 2021-04, Vol.87 (4), p.1717-1729

2021

Volltextzugriff (PDF)

STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline

PLoS medicine, 2020-09, Vol.17 (9), p.e1003344-e1003344

2020

Volltextzugriff (PDF)

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients

Frontiers in pharmacology, 2022-09, Vol.13, p.967082-967082

2022

Volltextzugriff (PDF)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease

JHEP reports, 2023-12, Vol.5 (12), p.100896-100896, Article 100896

2023

Volltextzugriff (PDF)

Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm

CPT: pharmacometrics and systems pharmacology, 2022-01, Vol.11 (1), p.20-29

2022

Volltextzugriff (PDF)

Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

Journal of personalized medicine, 2017-01, Vol.7 (1), p.1

2017

Volltextzugriff (PDF)

CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis

Systematic reviews, 2018-11, Vol.7 (1), p.204-15, Article 204

2018

Volltextzugriff (PDF)

Effect of Genetic Variability in the CYP4F2 , CYP4F11 , and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response

Frontiers in pharmacology, 2017-05, Vol.8, p.323-323

2017

Volltextzugriff (PDF)

Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration

EBioMedicine, 2021-12, Vol.74, p.103728-103728, Article 103728

2021

Volltextzugriff (PDF)

A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

JMIR research protocols, 2023-07, Vol.12, p.e46710-e46710

2023

Volltextzugriff (PDF)

Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med . 2017, 7 , 1

Journal of personalized medicine, 2018-05, Vol.8 (2), p.17

2018

Volltextzugriff (PDF)

Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7 , 19

Journal of personalized medicine, 2018-05, Vol.8 (2), p.18

2018

Volltextzugriff (PDF)

Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size

Journal of personalized medicine, 2017-12, Vol.7 (4), p.19

2017

Volltextzugriff (PDF)

Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study

Pediatric rheumatology online journal, 2018-02, Vol.16 (1), p.14-14, Article 14

2018

Volltextzugriff (PDF)

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials

British journal of clinical pharmacology, 2022-08, Vol.88 (8), p.3577-3599

2022

Volltextzugriff (PDF)

Role of Transporters and Enzymes in Metabolism and Distribution of 4‑Chlorokynurenine (AV-101)

Molecular pharmaceutics, 2024-02, Vol.21 (2), p.550-563

2024

Volltextzugriff (PDF)

Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda

Clinical pharmacology and therapeutics, 2021-06, Vol.109 (6), p.1564-1574

2021

Volltextzugriff (PDF)

Genetic testing for prevention of severe drug-induced skin rash

Cochrane library, 2013-12

2013

Volltextzugriff (PDF)

WITHDRAWN: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers

Journal of hepatology, 2018-05

2018

Volltextzugriff (PDF)

Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonists

Pediatric allergy and immunology, 2021-08, Vol.32 (6), p.1197-1207

2021

Volltextzugriff (PDF)

Adrenal responses to a low-dose short synacthen test in children with asthma

Clinical endocrinology (Oxford), 2016-05, Vol.84 (5), p.793-793

2016

Volltextzugriff (PDF)

Su1780 CYP2C1917 Gain of Function Mutation is Associated With the Development of Peptic Ulcer Disease

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-502-S-502

2012

Volltextzugriff (PDF)

Individual patient data meta-analysis : Cervical stitch (cerclage) for preventing pregnancy loss in women

BMC pregnancy and childbirth, 2005-02, Vol.5 (1), p.5-5, Article 5

2005

Volltextzugriff (PDF)

WARFARIN DOSING ALGORITHM REFINEMENTS AFTER 7-9 DAYS OF THERAPY BASED ON PHARMACOGENETIC, PHARMACOKINETIC, CLINICAL, AND LABORATORY DATA

Journal of the American College of Cardiology, 2010-03, Vol.55 (10), p.A130.E1218-A130.E1218

2010

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Warfarin dosing algorithms: A systematic review

STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline

A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease

Stable warfarin dose prediction in sub‐Saharan African patients: A machine‐learning approach and external validation of a clinical dose–initiation algorithm

Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review

CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis

Effect of Genetic Variability in the CYP4F2 , CYP4F11 , and CYP4F12 Genes on Liver mRNA Levels and Warfarin Response

Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration

A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study

Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med . 2017, 7 , 1

Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7 , 19

Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size

Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study

Cardiovascular drugs and COVID‐19 clinical outcomes: a systematic review and meta‐analysis of randomized controlled trials

Role of Transporters and Enzymes in Metabolism and Distribution of 4‑Chlorokynurenine (AV-101)

Developing and Validating a Clinical Warfarin Dose‐Initiation Model for Black‐African Patients in South Africa and Uganda

Genetic testing for prevention of severe drug-induced skin rash

WITHDRAWN: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers

Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonists

Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry

Adrenal responses to a low-dose short synacthen test in children with asthma

Su1780 CYP2C1917 Gain of Function Mutation is Associated With the Development of Peptic Ulcer Disease

Individual patient data meta-analysis : Cervical stitch (cerclage) for preventing pregnancy loss in women

WARFARIN DOSING ALGORITHM REFINEMENTS AFTER 7-9 DAYS OF THERAPY BASED ON PHARMACOGENETIC, PHARMACOKINETIC, CLINICAL, AND LABORATORY DATA

Aktive Filter

Suchergebnisse filtern